Morgan Stanley analyst Vikram Purohit maintained a Hold rating on Genmab (GMAB – Research Report) today and set a price target of $31.00. The ...

In a report released today, Vikram Purohit from Morgan Stanley maintained a Hold rating on Ascendis Pharma (ASND – Research Report), with a ...

Harding Loevner International Equity ADR composite fell 7.9%, gross, behind the 7.5% decline of the MSCI ACWI ex US Index.

In this guide, you’ll find links to stores around the world that have either stock notifications, pre-orders, or actual stock available and we update it every day, to see if new stock has ...

Shares of RateGain Travel Technologies continued their decline for the eighth consecutive day on Tuesday (February 18) after the company revised its revenue guidance downward for the second time in ...